The three letters identify lysine, proline and valine in that order. Sequence order is part of the chemical identity, so the same amino acid composition in another order isn't an equivalent reference. Analytical characterization should be suited to the intended tripeptide. A general peptide purity label does not settle every sequence related question.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Tissue Research
KPV
In stock·Ships in 1–2 business days
KPV research material supplied with batch-level documentation. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size1 option
Select pack sizeSave 18% on kits
1 × 10 mg$47.99
In stockSelected size 10 mgSC-KP10-010
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Published report · Lot 2025292
Reports describe the tested lot. Match the lot on your label before interpreting results.
Compound context
What researchers study
KPV peptide is the short sequence lysine-proline-valine. It appears in research on cellular uptake and inflammatory signaling in defined experimental models. This listing supplies laboratory material, with the available quantities shown in the selector. Its short sequence does not eliminate the need for identity testing or establish a safe amount for personal use.
Published work has examined uptake associated with PepT1 in epithelial and immune cell systems alongside mouse colitis models. Those findings identify specific research questions rather than a clinical treatment claim. KPV peptide benefits discussed outside that context can lose the important distinctions between uptake, a signaling marker and a whole organism outcome.
Transporter expression can influence exposure inside a cell. A result in a system that expresses a particular transporter may not transfer to a system that lacks it. Record the cell model and the method used to establish uptake or response. An extracellular concentration alone does not prove how much intact sequence reached the relevant compartment.
Scope limitCheck sequence identity and the lot's analytical record before use in a defined laboratory method. Research material is not a treatment for inflammatory disease or a personal dosage product. No human administration guidance is supplied.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
PepT1 transports certain small peptides and is relevant to several published KPV experiments. Its presence and activity depend on the model. A response that appears in one cell system does not establish a universal uptake mechanism. The experimental record should retain the biological model rather than summarize the result as a general property of all cells.
Changes in inflammatory markers can have several explanations, including differences in viability or background stimulation. Appropriate controls help distinguish those possibilities. An assay result should identify the marker and observation period. It cannot by itself show relief of a disease or justify taking a research compound outside laboratory work.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateKPV · Lot 2025292Liquilabs s.r.o.View report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
